NASDAQ:MACK
Merrimack Pharmaceuticals Stock News
$15.00
-0.0300 (-0.200%)
At Close: May 03, 2024
Merrimack Pharmaceuticals Issues Letter to Shareholders
01:00pm, Monday, 26'th Aug 2019
Company’s Board has Taken Crucial Actions to Maximize Shareholder Value and Preserve More than $500 Million in Potential Future Milestone Payments
JFL Capital Issues Letter to Fellow Merrimack Stockholders
12:30pm, Thursday, 22'nd Aug 2019
Believes Significant Destruction of Value and Lack of Alignment with Stockholders Warrants an Overhaul in the Boardroom Highlights Potential Paths Forward to Unlock Stockholder Value that JFL Capital
JFL Capital Issues Letter Criticizing Board, Appoints New Nominees
12:00am, Thursday, 22'nd Aug 2019Merrimack Pharmaceuticals Reschedules 2019 Annual Meeting of Shareholders for October 17, 2019
01:15pm, Friday, 16'th Aug 2019
Merrimack Pharmaceuticals (MACK) (the “Company” or “Merrimack”) announced today it is rescheduling its 2019 Annual Meeting of Shareholders (the “2019 Annual Meeting”) for October 17, 2019.
Merrimack Pharma To Reschedule 2019 Annual Shareholder Meeting From Oct. 17, 2019 To Sept. 16, 2019
12:00am, Friday, 16'th Aug 2019Merrimack Declares $20 Million Special Dividend
12:30pm, Thursday, 25'th Jul 2019
CAMBRIDGE, Mass., July 25, 2019 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. (MACK) today announced that its Board of Directors has authorized and declared a special cash dividend of $20 million o
